Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 411-418

  Griffin, Brenda W ^a   Magnino, Peggy E ^a   Pang, Iok Hou ^a   Sharif, Najam A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 16 PHENOXYPROSTAGLANDIN F2 ALPHA; 17 PHENYLPROSTAGLANDIN E2; 17 PHENYLPROSTAGLANDIN F2 ALPHA; CLOPROSTENOL; ENPROSTIL; FLUPROSTENOL; PHXA 85; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG POTENCY; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; CELLS, CULTURED; ESTRENES; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLINOSITOLS; PROSTAGLANDINS F, SYNTHETIC; PYRROLIDINONES; RATS; RECEPTORS, PROSTAGLANDIN;

EID: 0031846357     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2α stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem 271:1179-1186.
2. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM and Grygorczyk R (1994) Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269:2632-2636.
3. Berridge MJ, Downes CP and Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidyinositol responses in brain and salivary gland. Biochem J 206:587-595.
4. Bito LZ (1997) Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect. Surv Ophthalmol 41(Suppl 22):S1-S14.
5. Boie Y, Sawyer N, Slipetz DM, Metters KM and Abramovitz M (1995) Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 270:18910-18916.
6. Chegini N, Lei ZM, Rao ChV and Hansel W (1991) Cellular distribution and cycle phase dependency of gonadotropin and eicosanoid binding sites in bovine corpora lutea. Biol Reprod 45:506-513.
7. Chen J, Champa-Rodriguez ML and Woodward DF (1995) Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br J Pharmacol 116:3035-3041.
8. Coleman RA, Kennedy I, Humphrey PPA, Bunce K and Lumley P (1990) Prostanoids and their receptors, in Comprehensive Medicinal Chemistry, Vol. 3: Membranes and Receptors (Emmett JC ed) pp 643-714, Pergamon Press, Oxford.
9. Coleman RA, Smith WL and Narumiya S (1994) VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229.
10. 2α binding sites in the bovine iris ciliary body. Invest Ophthalmol Vis Sci 34: 2237-2245.
11. 2+ in bovine luteal cells. Proc Natl Acad Sci USA 84:3728-3732.
12. Dorn GW, II, Becker MW and Davis MG (1992) Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 267:24897-24905.
13. 2+ influx: How many mechanisms for how many channels? TIPS 15:77-83.
14. Goh Y and Kishino J (1994) Pharmacological characterization of prostaglandin-related ocular hypotensive agents. Jpn J Ophthalmol 38:236-245.
15. 2α from the ovine corpus luteum. Endocrinology 136:3430-3436.
16. Griffin BW, Williams GW, Crider JY and Sharif NA (1997) FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study. J Pharmacol Exp Ther 281:845-854.
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
18. Hughes AD and Schachter M (1994) Multiple pathways for entry of calcium and other divalent cations in a vascular smooth muscle cell line (A7r5). Cell Calcium 15:317-330.
19. Lake S, Gullberg H, Wahlqvist J, Sjögren A-M, Kinhult A, Lind P, Hellström-Lindahl E and Stjernschantz J (1994) Cloning of the rat and human prostaglandin F2α receptors and the expression of the rat prostaglandin F2α receptor. FEBS Lett 355:317-325.
20. Markwardt KL, Magnino PE and Pang I-H (1996) Effect of histamine on phosphoinositide turnover and intracellular calcium in human ciliary muscle cells. Exp Eye Res 62:511-520.
21. Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon O-J, Croxtall J, Barnes PJ and Vane JR (1994) Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 113:1008-1014.
22. 4 and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem Pharmacol 53:1249-1255.
23. 2α receptor of mouse 3T3 fibroblasts and its functional expression in Xenopus laevis oocytes. J Cell Physiol 155:257-264.
24. Namba T, Oida H, Sugimoto Y, Kakizuka A, Negishi M, Ichikawa A and Narumiya S (1994) cDNA cloning of the mouse prostacyclin receptor. J Biol Chem 269:9986-9992.
25. Narumiya S (1994) Prostanoid receptors: Structure, function, and distribution, in Cellular Generation, Transport, and Effects of Eicosanoids: Biological Roles and Pharmacological Intervention (Goetzl EJ, Lewis RA and Rola-Pleszczynski M eds) pp 126-138, The New York Academy of Sciences, New York, NY.
26. Pierce KL, Bailey TJ, Hoyer PB, Gil DW, Woodward DF and Regan JW (1997) Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J Biol Chem 272:883-887.
27. 2α receptor in bovine corpus luteum plasma membranes. Eur J Biochem 61:605-611.
28. 2α receptor. J Biol Chem 269:3881-3886.
29. Senoir J, Marshall K, Sangha R and Clayton JK (1993) In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 108:501-506.
30. 1-selective antagonist for ocular use. Receptor binding and second messenger studies. J Ocular Pharmacol 10:653-664.
31. Sharif NA, Xu SX, Miller ST, Gamache DA and Yanni JM (1996a) Characterization of the ocular anti-allergic and anti-histaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278:1252-1261.
32. Sharif NA, Xu SX, Magnino PE and Pang I-H (1996b) Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: Role in ocular allergic and inflammatory diseases. Exp Eye Res 63:169-178.
33. Sugimoto Y, Hasumoto K-Y, Namba T, Irie A, Katsuyama M, Negishi M, Kakizuka A, Narumiya S and Ichikawa A (1994) Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem 269:1356-1360.
34. 1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129: 2845-2856.
35. 2, and their esters in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 31:2466-2470.
36. 2+ signaling in vitro: serotonin-mediated cell-cell communication in mast cell/smooth muscle cocultures. J Cell Physiol 160:389-399.
37. 2+ transients evoked by proetanoids in Swiss 3T3 cells suggest an FP-receptor mediated response. Adv Prostaglandin Thromboxane Leukotriene Res 21:367-370.
38. 2+ signals in Swiss 3T3 cells. Biochem Pharmacol 47:1567-1574.
39. Woodward DF, Fairbairn CE, Krauss AH-P, Lawrence RA and Protzman CE (1995) Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins. J Pharmacol Exp Ther 273:285-291.
40. Yousufzai SYK, Chen A-L and Abdel-Latif AA (1988) Species differences in the effects of prostaglandins on inositol trisphosphate accumulation, phosphatidic acid formation, myosin light chain phosphorylation and contraction in iris sphincter of the mammalian eye: Interaction with the cyclic AMP system. J Pharmacol Exp Ther 247:1064-1072.